|
|
|
HomebuilderStocks.com Reports: Commerce Department Announces Record Levels of Single Family Home Sales in June
HomebuilderStocks.com Reports: Commerce Department Announces Record Levels of Single Family Home Sales in June US Department Of Commerce Report States That Single Family Home Sales for June Increased By 1.4% over May POINT ROBERTS, WA. July...
|
HomebuilderStocks.com Exclusive Article: Unified Building Codes Offer Nationwide Growth Opportunities for Homebuilding Sector
News Release November 17, 2004 HomebuilderStocks.com Exclusive Article: Unified Building Codes Offer Nationwide Growth Opportunities for Homebuilding Sector POINT ROBERTS, WA. November 17th, 2004 - www.HomebuilderStocks.com (HBS), a global...
NaturalGasStocks.com Updates “Online Investor Audio Forum”: Syntroleum Corporation (NASDAQ: SYNM) Added to List of Participating Public Companies
NaturalGasStocks.com Updates “Online Investor Audio Forum”: Syntroleum Corporation (NASDAQ: SYNM) Added to List of Participating Public Companies POINT ROBERTS, Wash., Delta, B.C, November 16th 2004 - NaturalGasStocks.com (NGS), a global...
|
|
Finding Undervalued Stocks 2 - Revisiting Graham's Rules
In a previous article, we discussed Ben Graham's Net Current Asset Value (NCAV) strategy and how it works. Here we will revisit Graham's rules, which were fairly severe in their original form in that they required the price of the stocks under...
|
|
|
|
|
HomelandDefenseStocks.com Reports on Biodefense Stocks Following Recent VaxGen $877.5M Contract
HomelandDefenseStocks.com Reports on Biodefense Stocks Following Recent VaxGen $877.5M Contract
POINT ROBERTS, Wash. Nov 08, 2004 - www.HomelandDefenseStocks.com, (HDS), an investor news portal for the Homeland Defense and Security Sector, presents an exclusive article on the likelihood of a bioterror attack, and the latest contract let under the "Project Bioshield" initiative to purchase Anthrax vaccines. Biodefense stocks gained traction in the market as shares of VaxGen increased twenty percent on news that the U.S. government was buying 75 million doses of its anthrax vaccine, valued at $877.5 million. Other biodefense stocks including Hollis-Eden, a company working on a drug targeting the acute effects of radiation injury, increased share price. The VaxGen contract is a significant milestone in the biodefense sector and gives confidence to the market of continued funding from Project BioShield.
Aethlon Medical, Inc. (OTCBB: AEMD) recently announced it is sponsoring the second annual “Crossing Boundaries: International Biodefense & Civilian Medicine” conference, on November 21-23 in Washington. Aethlon's Chief Scientific Officer, Dr. Richard Tullis, will give a presentation at the conference entitled: "The Hemopurifier™ as a treatment for drug and vaccine resistant bioweapons." George Mason University, the National Center for Biodefense, and The Burnham Institute are hosting the conference that will feature advances in medical biodefense including non-vaccine therapeutic approaches and products, and how these therapies could be applied to civilian medical research.
HDS does not make recommendations, but offers a unique, free information portal to investors to research news, articles, interviews and a growing list of participating public companies.
Article Excerpt: Major Vaccine contract boosts share price. More to come…
By Allen R. Gibson
Nov 2004
VaxGen Inc. has finally received the contract to supply 75 million doses of Anthrax vaccine to the US government; working on closing this contract for more than two years .The contract is worth $877.5 million dollars.
VaxGen shares surged up over 20% on over 5 million volume the day after it received the contract as part of the $5.6 billion "Bio Shield" initiative.
Health and Human Services Secretary Tommy G. Thompson noted when the bill was passed, "Bio Shield will also speed R&D on next-generation countermeasures for other dangerous pathogens, such as Ebola and plague. And it will give the FDA the ability to make promising new treatments available quickly in emergency situations."
Such research, along with stockpiling of vaccines, may be none too soon. A recent study conducted in England says that Bioterror is by far the most likely attach scenario we face. The report, prepared for the British Medical Association, says that, left unchecked, advances in biotechnology could equip terrorists to do as much damage as did the 1918 Spanish Flu epidemic, which killed more US soldiers than all the battles of WW1. Malcolm Dando, the reports author, says controlling biotech is going to be more difficult than the nuclear proliferation issue, and that the "window of opportunity" to take on the spread of such biological weapons is
shrinking fast.
For the complete article, click here:
http://www.homelanddefensestocks.com/Companies/HomelandDefense/HDS/Vaccine.asp
HDS Featured Profiled Company:
Aethlon Medical, Inc. (OTCBB: AEMD) Biodefense - www.AethlonMedical.com - Pioneering the development of viral filtration devices to treat HIV/AIDS, Hepatitis-C (HCV), and pathogens that are mass-casualty biological warfare candidates.
HomelandDefenseStocks.com includes a growing list of public companies in the sector. Click here for a partial list of companies involved in homeland defense and security technology and solutions in Airport Security, Biodefense, Biometrics, Defense, Internet Security, Integrated Security, Military, Border and Port Security.
http://www.HomelandDefenseStocks.com/Companies/HomelandDefense/Stock_List.asp
HomelandDefenseStocks.com is a Registered WA Trade Name, Federal Trade Mark Filed and Pending
Disclaimer: ECON Investor Relations Inc is the owner of this domain. ECON is a privately owned corporate communications company specializing in: investor relations, media relations, and research on public companies and industry sectors; for the investment community. Nothing on our sites should be construed as an offer or solicitation to buy or sell any specific products or securities. All investments involve risk. Past performance does not guarantee future results, therefor investigate before you invest! Although we attempt to research thoroughly, we offer no guarantees as to the accuracy of any information presented. We encourage all investors to use our sites only as a resource to further their own research. The site is compensated by its "Featured Companies, as outlined in our
on-line disclaimer at www.InvestorIdeas.com/About/Disclaimer.asp
The site is currently compensated for by its "featured companies." Markland Technologies, Inc. currently pays ECON Ten Thousand Dollars per month. Markland has issued shares to ECON in the past and these payments are for the purpose of including Markland in articles and other promotions. Aegis Assessments, Inc.: Four thousand dollars per month. Aethlon Medical, Inc.: Three Thousand Dollars per month plus restricted shares equivalent to Five Thousand Dollars per month. Law Enforcement Associates: Four thousand dollars per month. MDM Group, Inc.: Three Thousand Dollars per month, plus Twenty Thousand shares per month. OnScreen Technology Inc: Three Thousand Dollars, Roaming Messenger, Inc.: Two Thousand Dollars per month and One Thousand Dollars per month equivalent in shares. Snocone Systems, Inc.: Four thousand dollars per month. Bulldog Technologies, Inc.: One Thousand Dollars per month featured Company on HDS current list of stocks. Gabriel Technologies Corp: One Thousand Dollars per month featured Company on HDS current list of stocks.
Contact:
Dawn Van Zant / Trevor Ruehs
Toll free: 800-665-0411
Email: dvanzant@HomelandDefenseStocks.comm, truehs@HomelandDefenseStocks.com
About the author:
HDS does not make recommendations, but offers a unique, free information portal to investors to research news, articles, interviews and a growing list of participating public companies.
|
|
|
|
|
|
